AstraZeneca drug cocktail succeeds in late-stage study to treat Covid-19

Credit: IndiaTimes- Published on October 11, 2021
"An early intervention with our antibody can give a significant reduction in progression to severe disease, with continued protection for more than six months," said Mene Pangalos, executive vice president, biopharmaceuticals R&D at AstraZeneca.

You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions

COVID-19

Contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Two Mumbaikars have tested positive for Omicron, taking the tally of the new Covid variant in Maharashtra to 10, according to the state health update on Monday.
Credit: IndiaTimes - Published 3 hours ago

The Delta variant of Covid-19 delayed the wedding of Mayank and Khushi Bansal (names changed on request) from March to last week. And now Omicron has forced this..
Credit: IndiaTimes - Published 4 hours ago

The Omicron variant of COVID is already causing up to 1,000 infections a day, many more than official figures would suggest, a leading scientist has told Sky..
5 hours ago • Sky News
The scientific advisory group on Covid immunisation has deferred โ€œany decision on additional doseโ€ in the absence of consensus on whether there is a need to..
Credit: IndiaTimes - Published 5 hours ago


AstraZeneca

British-Swedish pharmaceutical company
The next pandemic could be more deadly than COVID-19, according to one of the scientists behind the Oxford-AstraZeneca vaccine.
1 day ago • Sky News
Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the..
Credit: IndiaTimes - Published 4 days ago

The "trigger" behind extremely rare blood clot complications stemming from the Oxford/AstraZeneca vaccine may have been discovered, according to new research.
5 days ago • Sky News

You might like